Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
montelukast arachidonate 5-lipoxygenase small molecule NA drugbank , DGIDB Bronchoconstriction[MeSHID:D016084]
Rhinitis
Allergic
Perennial[MeSHID:D012221]
Maintenance[MeSHID:D008283]
Hay fever[MeSHID:D006255]
Asthma[MeSHID:D001249]
Hypersensitivity[MeSHID:D006967]
Inspiration function[MeSHID:D001239]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.28 approved unknown
montelukast arachidonate 5-lipoxygenase small molecule NA drugbank , DGIDB Bronchoconstriction[MeSHID:D016084]
Rhinitis
Allergic
Perennial[MeSHID:D012221]
Maintenance[MeSHID:D008283]
Hay fever[MeSHID:D006255]
Asthma[MeSHID:D001249]
Hypersensitivity[MeSHID:D006967]
Inspiration function[MeSHID:D001239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.28 approved unknown
montelukast leukotriene cyslt1 receptor NA Successful target TTD , DGIDB Bronchoconstriction[MeSHID:D016084]
Rhinitis
Allergic
Perennial[MeSHID:D012221]
Maintenance[MeSHID:D008283]
Hay fever[MeSHID:D006255]
Asthma[MeSHID:D001249]
Hypersensitivity[MeSHID:D006967]
Inspiration function[MeSHID:D001239]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.78 approved unknown
montelukast cysteinyl leukotriene receptor 1 small molecule NA drugbank , DGIDB Bronchoconstriction[MeSHID:D016084]
Rhinitis
Allergic
Perennial[MeSHID:D012221]
Maintenance[MeSHID:D008283]
Hay fever[MeSHID:D006255]
Asthma[MeSHID:D001249]
Hypersensitivity[MeSHID:D006967]
Inspiration function[MeSHID:D001239]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.78 approved antagonist
montelukast cysteinyl leukotriene receptor 1 small molecule NA drugbank , DGIDB Bronchoconstriction[MeSHID:D016084]
Rhinitis
Allergic
Perennial[MeSHID:D012221]
Maintenance[MeSHID:D008283]
Hay fever[MeSHID:D006255]
Asthma[MeSHID:D001249]
Hypersensitivity[MeSHID:D006967]
Inspiration function[MeSHID:D001239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.78 approved antagonist
montelukast leukotriene cyslt1 receptor NA Successful target TTD , DGIDB Bronchoconstriction[MeSHID:D016084]
Rhinitis
Allergic
Perennial[MeSHID:D012221]
Maintenance[MeSHID:D008283]
Hay fever[MeSHID:D006255]
Asthma[MeSHID:D001249]
Hypersensitivity[MeSHID:D006967]
Inspiration function[MeSHID:D001239]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.78 approved antagonist
montelukast leukotriene cyslt1 receptor NA Successful target TTD , DGIDB Bronchoconstriction[MeSHID:D016084]
Rhinitis
Allergic
Perennial[MeSHID:D012221]
Maintenance[MeSHID:D008283]
Hay fever[MeSHID:D006255]
Asthma[MeSHID:D001249]
Hypersensitivity[MeSHID:D006967]
Inspiration function[MeSHID:D001239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.78 approved unknown
montelukast leukotriene cyslt1 receptor NA Successful target TTD , DGIDB Bronchoconstriction[MeSHID:D016084]
Rhinitis
Allergic
Perennial[MeSHID:D012221]
Maintenance[MeSHID:D008283]
Hay fever[MeSHID:D006255]
Asthma[MeSHID:D001249]
Hypersensitivity[MeSHID:D006967]
Inspiration function[MeSHID:D001239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.78 approved antagonist
click here to return to the previous page